Pharmaceuticals

Sort by Latest
Strengthened Environmental Risk Assessment requirements under the proposed new directive on medicinal products for human use
This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation....
June 23, 2023
3 min read
What the replication crisis means for AI and drug discovery
Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how...
May 4, 2023
2 min read
Revamping the European pharmaceutical industry: A closer look at the EU’s proposed legislative framework
On 26 April 2023, the European Commission published the long-anticipated proposal for the revision of...
April 28, 2023
3 min read
Guide to EU and UK Pharmaceutical Regulatory Law 2023
Eighth Edition, Edited by Sally Shorthose The Guide to EU and UK Pharmaceutical Regulatory...
January 31, 2023
3 min read
The Legal 500: Pharmaceutical Advertising Comparative Guide 2022
The latest edition of the Legal 500: Pharmaceutical Advertising Comparative Guide is now online. The...
December 12, 2022
1 min read
Rebranding generics as branded medicines – CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with...
December 9, 2022
5 min read
Dialogue at EU level on the legalisation of recreational cannabis – the German Federal Government’s White Paper will not suffice
The Federal Government submits its White Paper on the legalisation of recreational cannabis to the...
December 1, 2022
11 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read